Savings Program Brochure

Join My Tears, My Rewards® for
Savings & Support

Savings With Every Prescription*†

Just sign up here to get your My Tears, My Rewards® Program Savings Card. (You can also obtain a My Tears, My Rewards® Program Savings Card from your eye doctor.)

As soon as you call and activate your card, you can start saving on every
RESTASIS® prescription.


90-Day Prescription Savings
  • You may pay no out-of-pocket expenses up to $90 on every
    prescription refill
    during a year
  • And, if you fill your first prescription within 10 days of activating your
    My Tears, My Rewards® Program Savings Card, you get an
    additional $10 in savings

30-Day Prescription Savings
  • You may get up to $20 off your first, second, and third prescription
    copays§

    - $10 off your prescription PLUS an additional $10 if you fill the
       prescription within 10 days of activating your Program Savings
       Card per Visa.

  • On every fourth prescription refill, you pay no out-of-pocket costs
    up to $75

    - This includes your fourth, eighth, and twelfth refills in a year


Support Dialogue Bubble

Membership in this program is free and by signing up now, you
also receive:

  • Helpful communications about your treatment journey
  • Access to the RESTASIS® Patient Support Center, where trained
    representatives and nurses can answer your questions
  • Free samples of REFRESH® Lubricant Eye Drops, that may be
    used while you wait to notice more of your own real tears with RESTASIS®
  • Download of the MyTears® iPhone app to help with dosing
    reminders, and to log your perceived tear production and artificial
    tear use

Read the program's Terms and Conditions.


To receive your Program savings, support materials, information and special offers from RESTASIS®, please complete the information below

If your prescription will be paid in part or in whole by a federal or state healthcare program, you do not qualify for the My Tears, My Rewards® Program. However, you DO qualify for the My Tears, My Support™ Program, which offers free information and counseling to help you throughout your treatment journey. Sign up here!


*Required information














*Are you currently using RESTASIS®?
Yes    No

Yes, I would like to receive other communications from Allergan, Inc.


Sign up for the chance to participate in market research.

Allergan occasionally engages third-party firms to conduct consumer-based market research studies about our products or the health conditions they treat. By checking this box and opting in and providing the requested information, you are agreeing to be contacted about future research opportunities. Your information will only be used for the purpose of market research and will not be sold or distributed to any outside party for any other use.



See Allergan's Privacy Statement.



Approved Use
RESTASIS® (Cyclosporine
Ophthalmic Emulsion) 0.05% helps increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs.

Important Safety Information
Do not use RESTASIS® Ophthalmic Emulsion if you are allergic to any of the ingredients. To help avoid eye injury and contamination, do not touch the vial tip to your eye or other surfaces. See more below >

close

If you think you may have Chronic Dry Eye disease, don't wait!

*Required information









*Yes, I would like to receive information about RESTASIS® and other products and disease states from Allergan. I understand that I can opt-out of receiving e-mails at any time by clicking the unsubscribe link in any e-mail.

See Allergan's Privacy Statement.


close

You are about to leave restasis.com.

*Required information









*Yes, I would like to receive information about RESTASIS® and other products and disease states from Allergan. I understand that I can opt-out of receiving e-mails at any time by clicking the unsubscribe link in any e-mail.

See Allergan's Privacy Statement.